Five of the 10 best-performing stocks this year are traded on JASDAQ.

Bloomberg cite the example of Euglena, which is up 10-fold this year. The company said its developing single-cell algae based products, including jet fuel, which it expects to supply steadily by 2018. There’s also Japan Tissue Engineering, which is up by a factor of 9 this year after winning insurance-reimbursement approval from Japan’s Health Ministry for two types of manmade cartilage and skin.

Looks like Tokyo is the new wild west of technology investment with all that free Abenomics cash sloshing around.